Abstract
This study compared the safety and effectiveness of the diode laser and thulium laser during prostate transurethral vaporesection for treating benign prostate hyperplasia (BPH). We retrospectively analyzed 205 patients with BPH who underwent a diode laser or thulium laser technique for prostate transurethral vaporesection from June 2016 to June 2017 and who were followed up for 3 months. Baseline characteristics of the patients, perioperative data, postoperative outcomes, and complications were compared. We also assessed the International Prostate Symptom Score (IPSS), quality of life (QoL), maximum flow rate (Qmax), average flow rate (AFR), and postvoid residual volume (PVR) at 1 and 3 months postoperatively to evaluate the functional improvement of each group. There were no significant differences between the diode laser and thulium laser groups related to age, prostate volume, operative time, postoperative hospital stays, hospitalization costs, or perioperative data. The catheterization time was 3.5 ± 0.8 days for the diode laser group and 4.7 ± 1.8 days for the thulium laser group (p < 0.05). Each group had dramatic improvements in IPSS, QoL, Qmax, AFR, and PVR compared with the preoperative values (p < 0.05), although there were no significant differences between the two groups. Use of both diode laser and thulium laser contributes to safe, effective transurethral vaporesection in patients with symptomatic BPH. Diode laser, however, is better than thulium laser for prostate transurethral vaporesection because of its shorter catheterization time. The choice of surgical approach is more important than the choice of laser types during clinical decision making for transurethral laser prostatectomy.
Similar content being viewed by others
References
Zhang X, Zeng X, Liu Y, Dong L, Zhao X, Qu X (2014) Impact of metabolic syndrome on benign prostatic hyperplasia in elderly Chinese men. Urol Int 93(2):214–219
Yin Z, Yang JR, Rao JM, Song W, Zhou KQ (2015) Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men. ASIAN J ANDROL 17(5):826–830
He LY, Zhang YC, He JL, Li LX, Wang Y, Tang J, Tan J, Zhong K, Tang YX, Long Z (2016) The effect of immediate surgical bipolar plasmakinetic transurethral resection of the prostate on prostatic hyperplasia with acute urinary retention. ASIAN J ANDROL 18(1):134–139
Nair SM, Pimentel MA, Gilling PJ (2016) A review of laser treatment for symptomatic BPH (benign prostatic hyperplasia). CURR UROL REP 17(6)
Gravas S, Bach T, Bachmann A, Drake M, Gacci M, Gratzke C, Madersbacher S, Mamoulakis C, Tikkinen KAO Management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). European Assoc Urology Guidelines 2016*ed 2016:32
Takada J, Honda N, Hazama H, Ioritani N, Awazu K (2016) Analysis of thermally denatured depth in laser vaporization for benign prostatic hyperplasia using a simulation of light propagation and heat transfer (secondary publication). LASER THERAPY 25(4):273–284
Fu WJ, Hong BF, Yang Y, Zhang X, Gao JP, Zhang L, Wang XX (2009) Vaporesection for managing benign prostatic hyperplasia using a 2-microm continuous-wave laser: a prospective trial with 1-year follow-up. BJU Int 103(3):352–356
Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53(2):382–389
Long Z, Zhang YC, He LY, Zhong KB, Tang YX, Huang K (2014) Comparison of transurethral plasmakinetic and transvesical prostatectomy in treatment of 100-149 mL benign prostatic hyperplasia. ASIAN J SURG 37(2):58–64
Leonardi R (2009) Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique. Prostate Cancer Prostatic Dis 12(3):277–280
Zhao Y, Liu C, Zhou G, Yu C, Zhang Y, Ouyang Y (2013) A retrospective evaluation of benign prostatic hyperplasia treatment by transurethral vaporization using a 1470 nm laser. Photomed Laser Surg 31(12):626–629
Herrmann TR, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M, Gross AJ (2010) Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol 28(1):45–51
Kim Y, Seong YK, Kim IG, Han BH (2013) Twelve-month follow-up results of photoselective vaporization of the prostate with a 980-nm diode laser for treatment of benign hyperplasia. Korean J Urology 54(10):677
JIANG H, ZHOU Y (2016) Safety and efficacy of thulium laser prostatectomy versus transurethral resection of prostate for treatment of benign prostate hyperplasia: a meta-analysis. LUTS: Lower Urinary Tract Symptoms 8(3):165–170
Lee WC, Lin YH, Hou CP, Chang PL, Chen CL, Juang HH, Tsui KH (2013) Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males. Clin Interv Aging 8:1483–1488
Erol A, Cam K, Tekin A, Memik O, Coban S, Ozer Y (2009) High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia. J Urol 182(3):1078–1082
Barbalat Y, Velez MC, Sayegh CI, Chung DE (2016) Evidence of the efficacy and safety of the thulium laser in the treatment of men with benign prostatic obstruction. Ther Adv Urol 8(3):181–191
Razzaghi MR, Mazloomfard MM, Mokhtarpour H, Moeini A (2014) Diode laser (980 nm) vaporization in comparison with transurethral resection of the prostate for benign prostatic hyperplasia: randomized clinical trial with 2-year follow-up. Urology 84(3):526–532
Xu A, Zou Y, Li B, Liu C, Zheng S, Li H, Xu Y, Chen B, Xu K, Shen H (2013) A randomized trial comparing diode laser enucleation of the prostate with plasmakinetic enucleation and resection of the prostate for the treatment of benign prostatic hyperplasia. J Endourol 27(10):1254–1260
Wang L, Yu QY, Liu Y, Zhu ZL, Huang YW, Li K (2016) Efficacy and safety of laser surgery and transurethral resection of the prostate for treating benign prostate hyperplasia: a network meta-analysis. Asian Pac J Cancer Prev 17(9):4281–4288
Seitz M, Ackermann A, Gratzke C, Schlenker B, Ruszat R, Bachmann A, Stief C, Reich O, Sroka R (2007) Diode laser. Ex vivo studies on vaporization and coagulation characteristics. Urologe A 46(9):1242–1247
Nafie S, Dormer J, Khan MA (2017) The significance of histological analysis following laser transurethral resection of the prostate. Int Urol Nephrol 49(8):1343–1346
Skinner T, Leslie RJ, Steele SS, Nickel JC (2017) Randomized, controlled trial of laser vs. bipolar plasma vaporization treatment of benign prostatic hyperplasia. Can Urol Assoc J 11(6):194–198
Zhang X, Shen P, He Q, Yin X, Chen Z, Gui H, Shu K, Tang Q, Yang Y, Pan X, Wang J, Chen N, Zeng H (2016) Different lasers in the treatment of benign prostatic hyperplasia: a network meta-analysis. SCI REP-UK 6(1):23503
Peng M, Yi L, Wang Y (2016) Photoselective vaporization of the prostate vs plasmakinetic resection of the prostate: a randomized prospective trial with 12-month follow-up in mainland China. Urology 87:161–165
Li D, Jiang X, Zhang X, Yi L, Zhu X, Zeng X, Guo X, Tang Y (2012) Multicenter pathophysiologic investigation of erectile dysfunction in clinic outpatients in China. Urology 79(3):601–606
Funding
This study was supported by the Natural Science Foundation of Hunan Province (Grant No. 14JJ7004) and Innovation Foundation For Postgraduate of Central South University (Grant No. 2017zzts887).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Financial disclosure
The study was supported by the Natural Science Foundation of Hunan Province (Grant No. 14JJ7004) and Innovation Foundation For Postgraduate of Central South University (Grant No. 2017zzts887).
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
For this type of study, formal consent is not required.
Electronic supplementary material
ESM 1
(DOCX 18 kb)
Rights and permissions
About this article
Cite this article
Tan, X., Zhang, X., Li, D. et al. Transurethral vaporesection of prostate: diode laser or thulium laser?. Lasers Med Sci 33, 891–897 (2018). https://doi.org/10.1007/s10103-018-2499-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10103-018-2499-4